Perceptive Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-100,000
Closed -$3K 187
2016
Q4
$3K Buy
100,000
+99,000
+9,900% +$7.37M ﹤0.01% 174
2016
Q3
$250K Buy
+1,000
New +$80K 0.02% 157

Other funds holding LLY

Perceptive Advisors's LLY Position: Q3 2022 in Review

Perceptive Advisors sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 100,000 shares — an estimated $32.4M sold.

Perceptive Advisors first reported a position in LLY in Q2 2022 and held it in 1 quarter. The position peaked at $32.4M in Q2 2022. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Perceptive Advisors reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • Perceptive Advisors sold 100,000 Eli Lilly shares in Q3 2022, an estimated $32.4M.
  • Perceptive Advisors first reported a position in Eli Lilly in Q2 2022 and held it in 1 quarter.
  • Perceptive Advisors's Eli Lilly position peaked at $32.4M in Q2 2022.
  • 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Perceptive Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.